When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KPTI - Dosing underway in study of Karyopharm's selinexor in COVID-19
Karyopharm Therapeutics Inc.
The first subject has been dosed in a Phase 2 study assessing Karyopharm Therapeutics' (NASDAQ:KPTI) selinexor in severely ill COVID-19 patients. Total enrollment should be ~230.
More news on: Karyopharm Therapeutics Inc., Healthcare stocks news,